Subsequently, the expression of markers such as CD31 and MMP9 were used to indicate the extent of tumor angiogenesis and metastasis, respectively, and the CPPS-II + DOX group significantly downregulated the expression of CD31 and MMP9 in the tumor tissues and reduced the migration ability of tumors. This evidence concerns the gene PECAM1 and neoplasm.